Michael Lachman

Michael Lachman

Contributing Writer

Michael Lachman is President of EyeQ Research, which provides market research, analytics, and strategic advisory to ophthalmic companies and investors. Previously, he was a healthcare investment research analyst with Hambrecht & Quist, ThinkEquity Partners, and SAC Capital, and worked in business development, marketing, and R&D for Johnson & Johnson and Baxter.

  • All
  • Deals
  • Devices and Diagnostics
  • Digital
  • Genetics
  • Pharma
OIS Index Q2 2019

OIS Index Posts Modest Gain for Q2; Ophthalmic Market Leader Alcon Joins Index

The OIS Index of ophthalmic stocks posted a modest positive return of +0.8% during the second quarter of 2019. The index outperformed the NASDAQ Biotechnology ...
Read More
OIS Index

OIS Index Delivers Stellar First-Quarter 2019 Performance

The OIS Index of ophthalmic stocks solidly outperformed its market benchmarks in the first quarter of 2019, gaining 37.1%. During Q1, the overall US stock ...
Read More
OIS Index Follows the Stock Market Lower in December

OIS Index Follows the Stock Market Lower in December

The OIS Index declined 11% in December, marking the fourth month in a row in which ophthalmic stocks lost value. For the month, the overall ...
Read More
OIS Index

Market Rebounds in November; OIS Index Does Not

The OIS Index of ophthalmic stocks declined by 2.3% in November on the heels of a 17.7% decline in October, failing to participate in the ...
Read More
OIS Index

OIS Index Follows Stock Market Lower in October

The OIS Index of ophthalmic stocks declined by 17.7% during the October market correction, which saw a 7.5% decline in the overall US stock market ...
Read More
Small Cap Stocks Lead the Way for OIS Index in September

Small Cap Stocks Lead the Way for OIS Index in September

The OIS Index of ophthalmic stocks gave back some of its recent gains in September, declining by 4.1% against an overall flat market backdrop. The ...
Read More
OIS Index Follows the Stock Market Lower in December

Glaukos and STAAR Drive OIS Index into Record Territory

The OIS Index of ophthalmic stocks surged to new highs in August, driven by two of the highest-weighted stocks in the index. The OIS Index ...
Read More
OIS Index

OIS Index Lags Market Benchmarks in July

The OIS Index of ophthalmic stocks declined by 1.1% in July, against a strong overall market backdrop. During the month, the overall US stock market ...
Read More
OIS Index

OIS Index Hits New Highs; Two New Companies Added

The OIS Index stayed in four-digit territory in June, finishing the month at 1,017 and again outperforming its stock market benchmarks. The OIS Index gained ...
Read More
OIS Index Breaks 1,000 as Rally in Ophthalmic Stocks Rolls On

OIS Index Breaks 1,000 as Rally in Ophthalmic Stocks Rolls On

The OIS Index returned to four-digit territory in May, surpassing 1,000 for the first time since the index was launched in October 2016. The OIS ...
Read More
Ophthalmic Stocks' Rally Rolls Through April

Ophthalmic Stocks’ Rally Rolls Through April

The OIS Index gained 5.2% in April, on the heels of a 4.4% gain in March. Ophthalmic stocks have far outperformed key market benchmarks over ...
Read More
OIS Index

OIS Index Outperforms Market in Another Volatile Month

The OIS Index gained 4.4% in March, far outperforming its key benchmarks during another volatile month for the markets. The NASDAQ Biotechnology Index declined by ...
Read More